Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 8/20 | 0.49 |
| ▸ | ESR1 | P03372 | 7/20 | 0.49 |
| ▸ | TYR | P14679 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13788035 | 0.91 | TYR (0.56) | ESR2ESR1TYRCYP3A4ALOX15 | |
| SCHEMBL29373434 | 0.91 | TYR (0.56) | ESR2ESR1TYRCYP3A4ALOX15 | |
| SCHEMBL28597258 | 0.89 | ALOX5 (0.48) | ESR2ESR1ALOX5 | |
| SCHEMBL4063293 | 0.88 | AMY1A (0.56) | ESR2ESR1TYR | |
| SCHEMBL4061742 | 0.88 | AMY1A (0.56) | ESR2ESR1TYR | |
| SCHEMBL28693858 | 0.88 | ESR2 (0.45) | ESR2ESR1TYRCYP3A4ALOX15 | |
| SCHEMBL11200939 | 0.87 | ESR2 (0.52) | ESR2ESR1ALOX5 | |
| SCHEMBL278392 | 0.86 | AMY1A (0.42) | ESR2ESR1TYRALOX5 | |
| SCHEMBL4063920 | 0.86 | SHBG (0.43) | ESR2ESR1ALOX5HSD17B1 | |
| SCHEMBL22500098 | 0.86 | HSPA5 (0.59) | ESR2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2234494-B1 | PROTECTIVE LAYER FOR PLANTS AND TREES, THE PRODUCTION THEREOF AND USE THEREOF | STIFTUNG NANO INNOVATIONS (CH) | 2013-12-25 | — | — | EP | claimed |
| US-20130280523-A1 | COATING COMPOSITION HAVING A TITANIUM-DIOXIDE-PRODUCING AGENT, NANOSCALE TITANIUM-DIOXIDE-BASED COATING, AND PRODUCTION, FURTHER PROCESSING AND USE THEREOF | WILO SE (DE) | 2013-10-24 | — | — | US | claimed |
| EP-2598588-A2 | COATING COMPOSITION HAVING A TITANIUM-DIOXIDE-PRODUCING AGENT, NANOSCALE TITANIUM-DIOXIDE-BASED COATING, AND PRODUCTION, FURTHER PROCESSING AND USE THEREOF | WILO SE (DE) | 2013-06-05 | — | — | EP | claimed |
| WO-2012013335-A2 | COATING COMPOSITION HAVING A TITANIUM-DIOXIDE-PRODUCING AGENT, NANOSCALE TITANIUM-DIOXIDE-BASED COATING, AND PRODUCTION, FURTHER PROCESSING AND USE THEREOF | WILO SE (DE) | 2012-02-02 | — | — | WO | claimed |
| EP-1825752-B1 | Coating compound made of an agent which generates SiO2 with at least two antibacterial agents | STIFTUNG NANO INNOVATIONS FOR (CH) | 2009-11-18 | — | — | EP | claimed |
| EP-1826249-B1 | Utilisation of a coating compound for a container lock, container lock coating as antibacterial agent, its manufacture and application | STIFTUNG NANO INNOVATIONS FOR (CH) | 2008-12-24 | — | — | EP | claimed |
| EP-1826248-B1 | Container fastening coating composition, container fastening coating, its manufacture and application | STIFTUNG NANO INNOVATIONS FOR (CH) | 2008-12-24 | — | — | EP | claimed |
| EP-1826249-A1 | Utilisation of a coating compound for a container lock, container lock coating as antibacterial agent, its manufacture and application | Stiftung nano innovations -for a better living (CH) | 2007-08-29 | — | — | EP | claimed |
| EP-0956314-B1 | Refuse containers with biocide. | OTTO GMBH & CO KG GEB (DE) | 2000-10-18 | — | — | EP | claimed |
| EP-0029990-B1 | BIPHENYLMETHANE DERIVATIVE, METHODS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1982-09-08 | — | — | EP | claimed |
| EP-0029990-A1 | Biphenylmethane derivative, methods for its production and pharmaceutical compositions containing it | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1981-06-10 | — | — | EP | claimed |
| CN-119039113-B | Method for preparing 4,4' -methylenebis (2-hydroxymethyl-6-methylphenol) | 天津久日半导体材料有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-119039113-A | Method for preparing 4,4' -methylenebis (2-hydroxymethyl-6-methylphenol) | 天津久日半导体材料有限公司 | 2024-11-29 | — | — | CN | disclosed |
| US-20240101523-A1 | NOVEL BENZOXAZINE COMPOUND, RESIN RAW MATERIAL COMPOSITION CONTAINING THE SAME, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-03-28 | — | — | US | disclosed |
| CN-112041165-B | Additive manufacturing with efficient sintering using photothermal dyes | 株式会社理光 | 2024-01-09 | — | — | CN | disclosed |
| US-4225687-A | MOLDING MATERIALS | GENERAL ELECTRIC COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-4217438-A | Polycarbonate transesterification process | GENERAL ELECTRIC COMPANY (US) | 1980-08-12 | — | — | US | disclosed |
| US-4129678-A | POLYIMIDE, POLYAMIDEIMIDE OR POLYESTERIMIDE LAYER AND POLYVINYL FORMAL OR EPOXY RESIN LAYER | HITACHI, LTD. (JP) | 1978-12-12 | — | — | US | disclosed |
| US-4118370-A | ESTERIFIED HINDERED PHENOL; MOLDING MATERIALS, FIBERS, LAMINATES | GENERAL ELECTRIC COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-3991139-A | NORBORNENE DERIVATIVES, PHENOLS, ESTER THIOETHERS | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101523-A1 | NOVEL BENZOXAZINE COMPOUND, RESIN RAW MATERIAL COMPOSITION CONTAINING THE SAME, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | BRIX1, HAX1, DHX15 | ESR2 1874/4885ESR1 1313/4885TYR 1732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.